These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22283552)

  • 1. Amiodarone (Nexterone) injection for the treatment and prophylaxis of frequently recurring ventricular fibrillation.
    Marinelli A; Capucci A
    Expert Opin Pharmacother; 2012 Mar; 13(4):573-84. PubMed ID: 22283552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
    Van Herendael H; Dorian P
    Vasc Health Risk Manag; 2010 Aug; 6():465-72. PubMed ID: 20730062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PM101: intravenous amiodarone formulation changes can improve medication safety.
    Souney PF; Cooper WD; Cushing DJ
    Expert Opin Drug Saf; 2010 Mar; 9(2):319-33. PubMed ID: 20074019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous amiodarone.
    Med Lett Drugs Ther; 1995 Dec; 37(963):114-5. PubMed ID: 7500909
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous amiodarone for ventricular arrhythmias: overview and clinical use.
    Gonzalez ER; Kannewurf BS; Ornato JP
    Resuscitation; 1998; 39(1-2):33-42. PubMed ID: 9918445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
    Kudenchuk PJ; Cobb LA; Copass MK; Cummins RO; Doherty AM; Fahrenbruch CE; Hallstrom AP; Murray WA; Olsufka M; Walsh T
    N Engl J Med; 1999 Sep; 341(12):871-8. PubMed ID: 10486418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous amiodarone.
    Kowey PR; Marinchak RA; Rials SJ; Filart RA
    J Am Coll Cardiol; 1997 May; 29(6):1190-8. PubMed ID: 9137212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone: a new antiarrhythmic agent.
    Oyetayo OO; Rogers CE; Hofmann PO
    Pharmacotherapy; 2010 Sep; 30(9):904-15. PubMed ID: 20795846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous antiarrhythmic drug therapy in the resuscitation from refractory ventricular arrhythmias.
    Kudenchuk PJ
    Am J Cardiol; 1999 Nov; 84(9A):52R-55R. PubMed ID: 10568660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.
    Scheinman MM; Levine JH; Cannom DS; Friehling T; Kopelman HA; Chilson DA; Platia EV; Wilber DJ; Kowey PR
    Circulation; 1995 Dec; 92(11):3264-72. PubMed ID: 7586313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am J Cardiol; 1999 Nov; 84(9A):46R-51R. PubMed ID: 10568659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
    Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
    Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and therapeutic aspects of amiodarone induced thyroid dysfunction.
    Costache II; Aprotosoaie AC
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):375-9. PubMed ID: 24340519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects.
    Cushing DJ; Kowey PR; Cooper WD; Massey BW; Gralinski MR; Lipicky RJ
    Eur J Pharmacol; 2009 Apr; 607(1-3):167-72. PubMed ID: 19232340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amiodarone--still a useful antiarrhythmic drug].
    Gjesdal K
    Tidsskr Nor Laegeforen; 2008 Jun; 128(13):1532-3. PubMed ID: 18587462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should amiodarone or lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation?
    Leeuwenburgh BP; Versteegh MI; Maas JJ; Dunning J
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1148-51. PubMed ID: 18796471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced cardiac life support controversy: where do antiarrhythmic agents fit in?
    Chow MS
    Pharmacotherapy; 1997; 17(2 Pt 2):84S-88S; discussion 89S-91S. PubMed ID: 9085344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous amiodarone for treating acute life threatening arrhythmias.
    Votey SR; Herbert ME
    West J Med; 1998 Mar; 168(3):183. PubMed ID: 9549418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.